ANN ARBOR — Sooner or later, everyone faces decisions about whether or not to have surgery, take a new medication or have a cancer-screening test.
A new University of Michigan study published in Health Expectations explores the costs and benefits patients say are important in making these kinds of medical decisions, and how those costs and benefits explain what they actually decide to do. (more…)
UCLA infectious diseases doctor played key role in finance strategy for therapy
A new international program, conceived in part by a UCLA physician, has rapidly transformed access to lifesaving anti-malarial drugs by providing cheap, subsidized artemisinin-based combination therapies in seven African countries that account for a quarter of the world’s malaria cases.
The first independent evaluation of the Affordable Medicines Facility–malaria (AMFm) program was recently published in the journal The Lancet. The program is based at the Global Fund in Geneva, an international financing institution dedicated to disbursing funds to prevent and treat infectious diseases. The evaluation shows that the program improved access to key artemisinin combination therapies, or ACTs, which offer broader protection and less antibiotic resistance than anti-malaria medications currently available in those African nations. (more…)
Physicians are about half as willing to prescribe drugs tested in pharmaceutical-industry funded trials than those in NIH-funded studies, a new study finds.
Physicians are less likely to trust the results of clinical trials when they know those trials were funded by pharmaceutical companies, regardless of the quality of the research, a recent study in the New England Journal of Medicine shows.
The study, led by Dr. Aaron Kesselheim of the Harvard Medical School in Boston and co-authored by University of Arizona associate professor of law Christopher Robertson, evaluated physicians’ confidence in the results of drug trials conducted with a high, medium or low level of methodological rigor. It then looked at how their confidence in those same results changed when a trial’s funding source was revealed as either the National Institutes of Health or a company in the pharmaceutical industry, versus when no funding source was disclosed. (more…)
The phrase occurred to Joe Janes out of the blue one day and immediately appealed to him. From there, ideas began to flow quickly.
Janes, associate professor in the University of Washington Information School, had been a fan of the British Broadcasting Corp. radio series “A History of the World in 100 Objects” and thought those shows effectively blended history and storytelling.
He got to wondering, what if he took a similar approach to information, telling about the twists and turns of history — through documents? (more…)
*In a newly published study, researchers found the majority of medical residents surveyed experienced a decline in empathy over the course of the oft-used “long-call” shift.*
Fatigue and sleep deprivation are undisputed job descriptors for medical residents, but results from a new study indicate the common “long-call” shift may have adverse effects not only for residents, but also their patients.
University of Arizona alumna Stacey Passalacqua, now a visiting assistant professor at James Madison University’s School of Communication, surveyed nearly 100 medical residents at several different hospitals. (more…)
